Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Clinical trial NCT04685590 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04685590
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset Mild Cognitive Impairment

Start date: 2021-12-22
Primary completion: 2028-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.